We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EC:NYSEEcopetrol S.A. Analysis

Data as of 2026-08-10 - not real-time

$16.78

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Ecopetrol S.A. is bullish at $16.78, with short-term averages leading the long-term ones. The last 30 days have gained 16.1%. Momentum indicators put RSI at 56.9 (neutral) with MACD reading bullish. Watch $15.40 as support and $17.43 as the nearer resistance level.
Valuation screens as undervalued: a P/E of 11.1 sits below the sector average of 19.4. The average analyst target implies 19.7% below today's level. Revenue is growing at 35.5% on a 10.2% profit margin. The 3.87% dividend yield looks covered by current payout levels.
Risk comes out at 5 of a possible 10, a moderate reading. With 30-day volatility of 35.1%, a beta of -0.10 and a maximum drawdown of 16.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on buy, with conviction of 7/10.

Top Market Events

Ecopetrol announces the dates for the presentation of its second quarter 2026 results report and conference call PR...BOGOTÁ, Colombia, July 1, 2026 /PRNewswire/ -- Ecopetrol S.Ecopetrol S.A. NYSE:EC is one of the top cheap growth stocks to get rich. Ecopetrol S.A. NYSE:EC announced on June 16...

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 8/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 12.93
  • MACD momentum is positive

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 11.1 versus sector average of 19.4
  • Trading above the 200-day average of 12.93

Long Term

> 3 years
Positive
Model confidence: 7/10

Key Factors

  • P/E of 11.1 versus sector average of 19.4
  • Analyst targets imply -19.7% versus the current price
  • Revenue growth of +35.5%

Key Metrics & Analysis

Financial Health

Revenue Growth35.50%
Profit Margin10.23%
P/E Ratio11.1
ROE15.95%
ROA7.31%
Debt/Equity95.73
P/B Ratio0.0
Free Cash Flow$12150.2B
Industry P/E19.4

Technical Analysis

TrendBullish
RSI56.9
Support$15.40
Resistance$17.43
MA 20$16.34
MA 50$15.75
MA 200$12.93
MACDBullish
VolumeStable
Fear & Greed Index94.82

Valuation

Fair Value$206,402.71
Target Price$13.47
Upside/Downside-19.71%
GradeUndervalued
TypeValue
Dividend Yield3.87%

Risk Assessment

Beta-0.10
Volatility35.08%
Sector RiskHigh
Reg. RiskHigh
Geo RiskHigh
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.